Previous Close | 100.11 |
Open | 100.28 |
Bid | 66.00 x 900 |
Ask | 103.94 x 800 |
Day's Range | 98.53 - 100.60 |
52 Week Range | 45.38 - 103.66 |
Volume | |
Avg. Volume | 501,095 |
Market Cap | 4.993B |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Glaukos' (GKOS) shares have risen year to date on the back of strong fundamentals. However, rising costs can be a cause of concern.
While Glaukos Corporation ( NYSE:GKOS ) might not have the largest market cap around , it received a lot of attention...